Corcept Therapeutics is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented.

Corcept Therapeutics along with its key subsidiaries has a total of around 1328 patents/applications globally as of the date of the instant publication, out of which 439 patents have been issued. Of these 1328 patents/applications, more than 67.62% patents/applications are active. United States is where Corcept Therapeutics has filed the maximum number of patents, followed by Japan.

Most of the patents of the Corcept Therapeutics are in the classification of A61P and A61K, which indicates the core areas of technology focus of the company.

Some exemplary patents of Corcept Therapeutics Portfolio have been covered and demonstrated in this article and the instant article further indicates additional insights into the portfolio, such as worldwide patent filing activity, patent filing trend over the years, and many other statistics pertaining to the concerned entity. Certain other interesting innovations trends of the Corcept Therapeutics Portfolio have also been placed below for exemplary and illustration purposes only. A detailed report can also be generated and shared for any other entity on the lines desired, for which a simple email can be sent to [email protected] indicating the nature of insights required and the scope/intent of the study/exercise. We can also be contacted through www.iiprd.com, wherein IIPRD is a leading IP Asset Management and IP/Patent Support Practice with over 350 professionals spread across multiple jurisdictions in the US, India, South-East Asia, and the GCC.

To continue further, Corcept Therapeutics has a total of 1328 patents/applications filed globally. These patents/applications belong to 122 unique patent families. Out of 1328, 898 patents/applications are active/pending and 430 patent/applications are inactive.

The below graphical representation indicates yearly filing trends of the Corcept Therapeutics, which shows that the number of applications peaked in 2021 with 2023-2024 filings potentially still being recorded, indicating that the trend could rise further.

How many Corcept Therapeutics Portfolio patents are Alive/Dead?

Countries in which Corcept Therapeutics Filed Patents

10 Best Corcept Therapeutics Portfolio Patents

The patent US7928237 is the most cited in the portfolio, with 131 citations to date.

Corcept Therapeutics Portfolio Top 10 Inventors

Hunt Hazel Joan is the top inventor with 389 filings.

Patent Family with Most Filings

The patent family 61257610 has the highest number of filings worldwide, with 70 unique family members.

Disclaimer: This article is only being drafted/published for exemplary representation purposes based on public information and patent databases. The article does not, in any manner, intend to render any legal opinion, and also does not intend to warranty accuracy of the captured data being processed/represented. The analysis is only exemplary in nature, and therefore neither IIPRD nor any of its Partners, Employees, Associates, and/or Affiliates assume or admit any liability arising out of the same article and/or information provided therein.